Medical Devices & Tech

STENTYS

103 Carnegie Center
Princeton, NJ 08540 USA
Phone
Fax
Click for website

Research Sector Medical Devices & Tech

Summary Description Breakthrough treatment of Acute Myocardial Infarction

Management Gonzague Issenmann, Chief Executive Officer; Stanislas Piot, Chief Financial Officer; Hikmat Hojeibane, Chief Technology Officer; Rene Spaargaren, MD, Chief Medical Officer; Luc Morisset, Director Regulatory Affairs; Paul Geudens, VP Sales & Marketing; Benoit Vandenbossche, Director Operations

Click here for Financial Data
Keywords: cardiology, coronary, acute myocardial infarction, AMI, stent, DES, bifurcation

Comment


Updated: Dec. 08, 2013


Description

STENTYS offers simple, innovative solutions to interventional cardiologists when treating the challenging disease of their patients. When dealing with acute myocardial infarction or coronary artery di......view more

Products / Services

The STENTYS self-apposing stent is available in bare and drug-eluting (paclitaxel) forms.......view more

Technology / Differentiation

Conventional balloon-expandable stents may have a higher risk of thrombosis in AMI patients due to malapposition as a result of stent recoil, vasodilation and thrombus dissolution after the procedure....view more

Market / Customers

The market for the company's self-apposing stent platform is approximately $2.3 billion. The market for AMI stents, which represents about one third of PCIs today thanks to clinical evidence that prim......view more


Revenue / Funding

STENTYS successfully completed an IPO on NYSE EuroNext in Paris in October 2010 and raised $31.9m....view more

Analyst Coverage